The tumor promoter role and molecular mechanism of C8orf76/CALB2 axis in clear cell renal cell carcinoma

Read full text Summarise with VIRAT
Authors: Yuxiao Li, Pengju Liu, Xinyang Niu, Xueyou Ma, Jiazhu Sun, Suyuelin Huang, Yuchen Shi, Kai Yu, Feng-Hao Zhang, Xuan Shu, Zhixiang Qi, Dingheng Lu
+1 more Ben Liu
Cited by: 0
References: 45

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Clear cell renal cell carcinoma (ccRCC) is the predominant subtype of RCC. C8orf76 is upregulated in multiple cancers and linked to malignant progression, but its role in ccRCC remains unclear. Here, we explored the function and mechanism of C8orf76 in ccRCC using in vitro , in vivo , RNA-sequencing, and bioinformatic analyses. We found that C8orf76 and CALB2 were highly expressed in ccRCC and associated with poor prognosis. C8orf76 knockdown inhibited ccRCC proliferation and migration in vitro and in vivo by inducing G1 cell-cycle arrest and cellular senescence via downregulating CALB2, which could be partially reversed by CALB2 overexpression. Similarly, CALB2 knockdown induces cell-cycle arrest and cellular senescence in ccRCC, thereby inhibiting cell proliferation and migration. These effects are partially reversed by additional CDKN2A knockdown. Therefore, C8orf76 directly binds to the CALB2 promoter to activate its transcription. The C8orf76/CALB2 axis promotes ccRCC progression by repressing cellular senescence.

Fields of Study & Subjects

Renal cell carcinoma treatment Ferroptosis and cancer prognosis Cancer-related molecular mechanisms research

Publication details

Journal / source
iScience
Volume
29
Issue
5
Pages
115533–115533
Publication date
30 March 2026
Language
EN